Biomimetic Nanoscale Materials for Skin Cancer Therapy and Detection

Figure 2

Representative images of the gross morphological appearance of mice skin tumors (a) untreated (nontumor control); (b) after 17 weeks of subcutaneous DMBA injection (untreated control); (c) after GNPs treatment; (d) after nisin-GNPs treatment; (e) after Dox-GNPs treatment; (f) after nisin-Dox-GNPs treatment for 7 weeks after skin tumor induction. Photomicrographs of histopathology that correspond (a1–f1).